• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-451b通过靶向血管内皮生长因子A参与冠心病的发生发展。

MicroRNA-451b Participates in Coronary Heart Disease By Targeting VEGFA.

作者信息

Lin Jie, Jiang Jun, Zhou Ruifang, Li Xiaojie, Ye Jun

机构信息

Department of Cardiology, Taizhou People's Hospital, Taizhou 225300, China.

Taizhou Polytechnic College, Taizhou 225300, China.

出版信息

Open Med (Wars). 2019 Dec 26;15:1-7. doi: 10.1515/med-2020-0001. eCollection 2018.

DOI:10.1515/med-2020-0001
PMID:31922013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6944456/
Abstract

Coronary artery disease (CAD) is one of the main causes of hospitalization worldwide and has high morbidity. MicroRNAs (miRNAs) play an important role in the pathogenesis of cardiovascular diseases. miR-451 is a special miRNA that is involved in many cancers' development. At present, there is no research about miR-451 in coronary heart disease. In this study, we aimed to identify the action mechanism of miR-451 in coronary heart disease and human umbilical vein endothelial cells (HUVECs). In this study, we found that miR-451 is up-regulated in the peripheral blood of patients with coronary heart disease. Moreover, TargetScan and dual-luciferase reporter gene assay results showed that VEGFA is a direct target gene of miR-451. C (CCK-8) and flow cytometry assay results showed that miR-451 mimic significantly inhibits cell proliferation and promotes apoptosis in HUVECs. Moreover, we found that the role of miR-451 in HUVECs is associated with the PI3K-Akt-mTOR pathway. Taken together, the data indicates that miR-451 might be a novel bio-marker for coronary heart disease.

摘要

冠状动脉疾病(CAD)是全球范围内住院治疗的主要原因之一,发病率很高。微小RNA(miRNA)在心血管疾病的发病机制中起重要作用。miR-451是一种特殊的miRNA,参与多种癌症的发展。目前,尚无关于miR-451在冠心病中的研究。在本研究中,我们旨在确定miR-451在冠心病和人脐静脉内皮细胞(HUVECs)中的作用机制。在本研究中,我们发现冠心病患者外周血中miR-451上调。此外,TargetScan和双荧光素酶报告基因检测结果表明,VEGFA是miR-451的直接靶基因。CCK-8和流式细胞术检测结果表明,miR-451模拟物显著抑制HUVECs细胞增殖并促进其凋亡。此外,我们发现miR-451在HUVECs中的作用与PI3K-Akt-mTOR信号通路有关。综上所述,数据表明miR-451可能是冠心病的一种新型生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1915/6944456/1cde3d37d74f/med-15-001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1915/6944456/ac2da3aa4cc3/med-15-001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1915/6944456/1cde3d37d74f/med-15-001-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1915/6944456/ac2da3aa4cc3/med-15-001-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1915/6944456/1cde3d37d74f/med-15-001-g004.jpg

相似文献

1
MicroRNA-451b Participates in Coronary Heart Disease By Targeting VEGFA.微小RNA-451b通过靶向血管内皮生长因子A参与冠心病的发生发展。
Open Med (Wars). 2019 Dec 26;15:1-7. doi: 10.1515/med-2020-0001. eCollection 2018.
2
Downregulated miRNA-26a-5p induces the apoptosis of endothelial cells in coronary heart disease by inhibiting PI3K/AKT pathway.下调的 miRNA-26a-5p 通过抑制 PI3K/AKT 通路诱导冠心病内皮细胞凋亡。
Eur Rev Med Pharmacol Sci. 2019 Jun;23(11):4940-4947. doi: 10.26355/eurrev_201906_18084.
3
MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4.微小 RNA-9-5p 通过靶向 CXCR4 促进高糖诱导损伤的人脐静脉内皮细胞血管生成,但抑制其凋亡和炎症。
Int J Biol Macromol. 2019 Jun 1;130:1-9. doi: 10.1016/j.ijbiomac.2019.02.003. Epub 2019 Feb 2.
4
microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.microRNA-126 通过与 EGFL7 相互作用并下调 PI3K/AKT 信号通路抑制 HUVECs 的管形成。
Biomed Pharmacother. 2019 Aug;116:109007. doi: 10.1016/j.biopha.2019.109007. Epub 2019 Jun 3.
5
MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2.微小RNA-495通过靶向趋化因子CCL2来调节人脐静脉内皮细胞的增殖和凋亡。
Thromb Res. 2015 Jan;135(1):146-54. doi: 10.1016/j.thromres.2014.10.027. Epub 2014 Nov 6.
6
Integrated bioinformatics analysis identifies microRNA-376a-3p as a new microRNA biomarker in patient with coronary artery disease.综合生物信息学分析确定微小RNA-376a-3p为冠心病患者一种新的微小RNA生物标志物。
Am J Transl Res. 2020 Feb 15;12(2):633-648. eCollection 2020.
7
Apoptosis in HUVECs induced by microRNA-616-3p via X-linked inhibitor of apoptosis protein targeting.微小RNA-616-3p通过靶向X连锁凋亡抑制蛋白诱导人脐静脉内皮细胞凋亡
Exp Ther Med. 2021 Jun;21(6):661. doi: 10.3892/etm.2021.10093. Epub 2021 Apr 21.
8
MicroRNA-20a participates in the aerobic exercise-based prevention of coronary artery disease by targeting PTEN.微小 RNA-20a 通过靶向 PTEN 参与基于有氧运动的冠心病预防。
Biomed Pharmacother. 2017 Nov;95:756-763. doi: 10.1016/j.biopha.2017.08.086. Epub 2017 Sep 8.
9
Effect of microRNA-144-5p on the proliferation, invasion and migration of human umbilical vein endothelial cells by targeting SMAD1.微小RNA-144-5p通过靶向SMAD1对人脐静脉内皮细胞增殖、侵袭和迁移的影响
Exp Ther Med. 2020 Jan;19(1):165-171. doi: 10.3892/etm.2019.8194. Epub 2019 Nov 13.
10
MiR-155-5p inhibits the proliferation and migration of VSMCs and HUVECs in atherosclerosis by targeting AKT1.miR-155-5p 通过靶向 AKT1 抑制动脉粥样硬化中 VSMCs 和 HUVECs 的增殖和迁移。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2223-2233. doi: 10.26355/eurrev_201903_17270.

引用本文的文献

1
Epigenetic Mechanisms in Heart Diseases.心脏病中的表观遗传机制
Rev Cardiovasc Med. 2025 Jul 30;26(7):38696. doi: 10.31083/RCM38696. eCollection 2025 Jul.
2
MiR-451 in Inflammatory Diseases: Molecular Mechanisms, Biomarkers, and Therapeutic Applications-A Comprehensive Review Beyond Oncology.炎症性疾病中的MiR-451:分子机制、生物标志物及治疗应用——肿瘤学之外的全面综述
Curr Issues Mol Biol. 2025 Feb 16;47(2):127. doi: 10.3390/cimb47020127.
3
New Biomarkers for Cardiovascular Disease.心血管疾病的新型生物标志物。

本文引用的文献

1
lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma.长链非编码RNA LOC100132354通过VEGFA/VEGFR2信号通路促进肺腺癌血管生成。
Cancer Manag Res. 2018 Oct 5;10:4257-4266. doi: 10.2147/CMAR.S177327. eCollection 2018.
2
MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.微小RNA-451通过靶向CAB39经mTOR/HIF-1α/VEGF信号通路抑制胶质瘤细胞增殖和侵袭。
Hum Gene Ther Clin Dev. 2018 Sep;29(3):156-166. doi: 10.1089/humc.2018.133.
3
Effects of Olive Oil Phenolic Compounds on Inflammation in the Prevention and Treatment of Coronary Artery Disease.
Tex Heart Inst J. 2023 Oct 16;50(5). doi: 10.14503/THIJ-23-8178.
4
Identification of 5 hub genes for diagnosis of coronary artery disease.用于诊断冠状动脉疾病的5个核心基因的鉴定
Front Cardiovasc Med. 2023 Jul 5;10:1086127. doi: 10.3389/fcvm.2023.1086127. eCollection 2023.
5
Comprehensive Landscape of Modules-Dysregulated Functions Reveals a Profound Role of ceRNAs in Coronary Heart Disease.模块失调功能的综合全景揭示了 ceRNAs 在冠心病中的重要作用。
J Healthc Eng. 2022 Mar 8;2022:4547413. doi: 10.1155/2022/4547413. eCollection 2022.
6
MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application.微小 RNA 作为 2 型糖尿病相关冠状动脉疾病的生物标志物:从发病机制到潜在的临床应用。
Int J Mol Sci. 2022 Dec 29;24(1):616. doi: 10.3390/ijms24010616.
7
Integrated analysis of miRNA-mRNA regulatory network and functional verification of miR-338-3p in coronary heart disease.冠心病中miRNA-mRNA调控网络的综合分析及miR-338-3p的功能验证
Funct Integr Genomics. 2022 Dec 23;23(1):16. doi: 10.1007/s10142-022-00941-w.
8
miRNA in Ischemic Heart Disease and Its Potential as Biomarkers: A Comprehensive Review.miRNA 在缺血性心脏病中的作用及其作为生物标志物的潜力:全面综述。
Int J Mol Sci. 2022 Aug 12;23(16):9001. doi: 10.3390/ijms23169001.
9
Endothelial cell-derived extracellular vesicles impair the angiogenic response of coronary artery endothelial cells.内皮细胞衍生的细胞外囊泡会损害冠状动脉内皮细胞的血管生成反应。
Front Cardiovasc Med. 2022 Jul 19;9:923081. doi: 10.3389/fcvm.2022.923081. eCollection 2022.
10
A Network Pharmacology Study to Explore the Underlying Mechanism of Safflower () in the Treatment of Coronary Heart Disease.一项探索红花治疗冠心病潜在机制的网络药理学研究
Evid Based Complement Alternat Med. 2022 May 14;2022:3242015. doi: 10.1155/2022/3242015. eCollection 2022.
橄榄油酚类化合物在冠心病防治中的抗炎作用。
Nutrients. 2017 Sep 30;9(10):1087. doi: 10.3390/nu9101087.
4
Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.糖尿病患者功能失调的高密度脂蛋白及其在心血管疾病发病机制中的作用。
Mol Cell Biochem. 2018 Mar;440(1-2):167-187. doi: 10.1007/s11010-017-3165-z. Epub 2017 Aug 21.
5
Genetics of coronary artery disease: discovery, biology and clinical translation.冠状动脉疾病的遗传学:发现、生物学及临床转化
Nat Rev Genet. 2017 Jun;18(6):331-344. doi: 10.1038/nrg.2016.160. Epub 2017 Mar 13.
6
miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.微小RNA-451通过靶向白细胞介素-6受体-信号转导和转录激活因子3通路,发挥肝细胞癌血管生成抑制因子的作用。
Oncol Rep. 2016 Sep;36(3):1385-92. doi: 10.3892/or.2016.4971. Epub 2016 Jul 25.
7
Integrated microRNA, mRNA, and protein expression profiling reveals microRNA regulatory networks in rat kidney treated with a carcinogenic dose of aristolochic acid.整合的微小RNA、信使核糖核酸和蛋白质表达谱分析揭示了用致癌剂量马兜铃酸处理的大鼠肾脏中的微小RNA调控网络。
BMC Genomics. 2015 May 8;16(1):365. doi: 10.1186/s12864-015-1516-2.
8
Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases.循环微小RNA作为心血管疾病临床生物标志物的效用
Biomed Res Int. 2015;2015:821823. doi: 10.1155/2015/821823. Epub 2015 Feb 1.
9
Collaborative care for the treatment of comorbid depression and coronary heart disease: a systematic review and meta-analysis protocol.合并抑郁症和冠心病的协同治疗:一项系统评价与荟萃分析方案
Syst Rev. 2014 Oct 28;3:127. doi: 10.1186/2046-4053-3-127.
10
MicroRNAs - Biology and clinical applications.微小RNA——生物学与临床应用
J Oral Maxillofac Pathol. 2014 May;18(2):229-34. doi: 10.4103/0973-029X.140762.